Autopsy report · NCT04524715

LLLT Treatment of Lung Inflammation in COVID-19

“Based upon feedback from IRB.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Ward Photonics LLC

Sponsor type

Industry

Conditions

Covid19

Interventions

Non-invasive red LLLT treatment to chest of patient.; Sham Device Treatment

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Antenatal Development Evaluated Prospectively
  “Not IRB approved” (64% match in meaning)
• Comparing Fetoscopic Surgery Protocols
  “Deferred by IRB.” (62% match in meaning)
• Efficacy and Cost Effectiveness of Utilizing a Hydraulically Adjustable Walker in the Treatment of Hip Fracture
  “IRB -- need to reframe study as a feasibility study before it being a RCT.” (57% match in meaning)
• Coronary Artery Study in Pediatric Heart Transplantation
  “never approved by IRB” (57% match in meaning)
• Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
  “did not move forward with IRB approval, competing study” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.